| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jan 02, 2025 | Jan 03, 2025 | Brennan Kevin M. SVP FINANCE ACCOUNTING | Sell | Xilio Therapeutics, Inc. | XLO | $0.98 | $1,774 | -36.06% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.